Balaji Amines Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/eyx8xpffzjeea3obzqn5x898.pdf

Key Takeaways


Volume & Margin Recovery

Reddy: "Minimum 10%, I'm telling you. I'm telling you very conservatively, but minimum 10% without considering any expansions."

Specialty Chemicals: What's Weighing


Expansion Projects & New Products

Methylamines & DMF integration

EDA plant & value-added shift

Other product launches

BSC Unit 2 progress

Reddy: "It's too early to say, but definitely, it should cross INR 1,000 crores minimum with this unit 2 alone."

Battery Chemicals: Waiting for Customers

Reddy: "See, it is operating presently 30% to 40%. You are well aware these plants were meant for the lithium batteries. Actually, lithium batteries companies, last 4-5 years, they were talking. Last 4-5 years. Just in they were coming like this, they were talking. But unfortunately, nobody has done kickstart."

Energy & Infrastructure

Reddy: "Dimethyl ether, we don't have the license, but the Government of India is having a plan that they are going to make it mandatory to all the LPG manufacturers that they should blend 20% of dimethyl ether, mandatorily. That time, we will have the advantage as being a first manufacturer."

Guidance & Commitments

CommitmentSpecificsTimeline
Standalone volume growthMinimum 10%, conservatively, without considering any expansionsFY25
Consolidated EBITDA margin21% to 24% rangeFY25
Methylamines plant commissioningPlant operational, DMF and methylamines both at 100% capacityEnd of December 2024
Electronic grade DMC plantCommissioningFY 2024-25
Dimethyl ether manufacturing projectLaunch at Unit IVBy March 2025
Solar Phase 1 (8 MW)Operational, covering 60-70% of power billDecember 2024
EDA value-added product shiftLess EDA to market, more DETA/PIP/TETA/TEPA/PEHA visibleComing 1-2 quarters
BSC Unit 2 environmental clearanceExpected receiptEnd of May 2024 or early June 2024
Unit I debottleneckingCompletion of shutdowns2-3 months
Hotel expansion40 rooms added at ₹30-35 cr costNot specified

Key Metrics

MetricQ4 FY24
Consolidated revenue from operations₹423 cr, vs ₹392 cr in Q3 FY24
Standalone revenue from operations₹373 cr, vs ₹314 cr in Q3 FY24
Consolidated EBITDA₹106 cr, vs ₹83 cr in Q3 FY24
Consolidated EBITDA margin25%, vs 21% in Q3 FY24
Standalone EBITDA margin25%, vs 20% in Q3 FY24
Consolidated PAT₹72 cr, vs ₹56 cr in Q3 FY24
Consolidated diluted EPS₹21 per share, vs ₹15.24 in Q3 FY24
Total volume27,984 metric tons, vs 26,903 metric tons in Q3 FY24
Amines volumes8,910 metric tons
Amines derivatives volumes9,676 metric tons
Specialty Chemical volumes9,398 metric tons
Standalone volume growth guidance for FY25Minimum 10%, without considering any expansions
EBITDA margin guidance21% to 24%
DMF capacity utilization outlookMore than 70%, from Q1 FY25 onwards
DMC and propylene glycol plant capacity utilization30% to 40%
EDA plant capacity utilization in FY2442%, vs 72% last year
Hotel occupancy85% to 90%